bioRxiv / medRxivopen access
Randomized controlled trials do not support efficacy of any of the tested doses of fluvoxamine in prevention of disease progression in adults with incipient non-severe COVID-19 disease: a case-study systematic review and meta-analysis
pharmacology and therapeutics
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 150403
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.